In what has been billed as one of the biggest life science leases ever for the San Diego County market, Neurocrine Biosciences has leased 535,000 square feet of space in a Carmel Valley campus that is still under construction. The location will become the company’s new corporate headquarters.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Investment analysts at William Blair dropped their Q1 2024 EPS estimates for Neurocrine Biosciences in a report released on Wednesday, February 7th. William Blair analyst M. Minter now expects that the company will earn $1.04 per share for the quarter, down from their prior estimate of $1.19. […]
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) CFO Matt Abernethy sold 1,280 shares of the business’s stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $142.19, for a total transaction of $182,003.20. Following the transaction, the chief financial officer now owns 29,434 shares in the company, […]
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) CFO Matt Abernethy sold 980 shares of the business’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $134.21, for a total transaction of $131,525.80. Following the completion of the sale, the chief financial officer now owns […]
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) CFO Matt Abernethy sold 980 shares of the business’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $134.21, for a total value of $131,525.80. Following the transaction, the chief financial officer now directly owns 30,314 shares […]